Page last updated: 2024-09-05

dabigatran and Coagulation Disorders, Blood

dabigatran has been researched along with Coagulation Disorders, Blood in 20 studies

Research

Studies (20)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (5.00)	29.6817
2010's	17 (85.00)	24.3611
2020's	2 (10.00)	2.80

Authors

Authors	Studies
Nalezinski, S	1
Chen, H; Gu, H; Hu, L; Lin, X; Liu, H; Xu, Z; Yang, X	1
Manolopoulos, VG; Ragia, G	1
Birschmann, I; Blumenstock, G; Ebner, M; Härtig, F; Kuhn, J; Peter, A; Poli, S; Spencer, C; Ziemann, U; Zuern, CS	1
Levy, JH; Neal, MD	1
Faul, O; Gehring, FK; Hussain, M; Körber, MK; Langer, E; Northoff, H; Schmidt, K; von Heymann, C; Wendel, HP	1
Binet, Q; Hermans, C; Lambert, C	1
Gan, G; Grottke, O; Honickel, M; Rossaint, R; Spronk, HMH; Ten Cate, H; van Ryn, J; Zentai, C	1
Bachellerie, B; Conil, JM; Crognier, L; Fourcade, O; Georges, B; Ruiz, S; Seguin, T	1
Debasse, M; Jacquemin, M; Peerlinck, K; Peetermans, M; Schoeters, J; Toelen, J; van Horenbeeck, I; van Ryn, J; Vanassche, T; Vanlinthout, I; Verhamme, P	1
Ansell, JE	1
Ali, JT; Ali, S; Aydelotte, JD; Brown, CV; Coopwood, TB; Daley, MJ; Enright, Z; Nguyen, J; Teixeira, PG; Vadiei, N	1
Heindl, B; Spannagl, M	1
Mousa, SA	1
Asakura, H	1
Alpert, JS	1
Brouns, R; De Keyser, J; De Raedt, S; De Smedt, A; Jochmans, K; Luijckx, GJ; Moens, M; Uyttenboogaart, M; Van Hooff, RJ	1
Arnold, DM; Crowther, MA; Eltringham-Smith, LJ; Gataiance, S; Lambourne, MD; Sheffield, WP	1
Curnow, J; Dunkley, S; Kershaw, G; Khoo, TL; Reddel, CJ; Weatherburn, C	1
Chance, EA; Huang, GS	1

Reviews

5 review(s) available for dabigatran and Coagulation Disorders, Blood

Article	Year
Methods to Correct Drug-Induced Coagulopathy in Bleeding Emergencies: A Comparative Review. Laboratory medicine, 2022, Jul-04, Volume: 53, Issue:4 Topics: Anticoagulants; Blood Coagulation Disorders; Dabigatran; Emergencies; Hemorrhage; Humans; Vitamin K	2022
Reversing the Effect of Oral Anticoagulant Drugs: Established and Newer Options. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2016, Volume: 16, Issue:3 Topics: Administration, Oral; Animals; Antibodies, Monoclonal, Humanized; Anticoagulants; Antifibrinolytic Agents; Antithrombins; Arginine; Blood Coagulation Disorders; Blood Coagulation Factors; Coagulants; Combined Modality Therapy; Dabigatran; Drugs, Investigational; Enoxaparin; Factor Xa; Fibrinolytic Agents; Humans; Piperazines; Practice Guidelines as Topic; Recombinant Proteins; Vitamin K	2016
[New oral anticoagulants. Consequences for perioperative coagulation diagnostics and therapy]. Der Anaesthesist, 2009, Volume: 58, Issue:12 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; Blood Coagulation Disorders; Dabigatran; Factor Xa Inhibitors; Humans; International Normalized Ratio; Intraoperative Complications; Morpholines; Partial Thromboplastin Time; Pyridines; Rivaroxaban; Thiophenes; Thrombin; Thromboembolism	2009
[Interpretation of hemostatic and fibrinolytic markers]. Rinsho byori. The Japanese journal of clinical pathology, 2011, Volume: 59, Issue:10 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Biomarkers; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Dabigatran; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Partial Thromboplastin Time; Plasminogen Activators; Prothrombin Time; Thrombomodulin; Warfarin	2011
Acute stroke management in patients taking dabigatran. CNS neuroscience & therapeutics, 2012, Volume: 18, Issue:8 Topics: Anticoagulants; Benzimidazoles; Blood Coagulation Disorders; Case Management; Cerebral Hemorrhage; Cerebral Infarction; Dabigatran; Guidelines as Topic; Hemostasis; Hemostatics; Humans; Off-Label Use; Pyridines; Renal Dialysis; Reperfusion; Stroke; Vitamin K	2012

Other Studies

15 other study(ies) available for dabigatran and Coagulation Disorders, Blood

Article	Year
Dabigatran etexilate is efficacious in consumptive coagulopathy and pain associated with venous malformations. Journal of vascular surgery. Venous and lymphatic disorders, 2023, Volume: 11, Issue:2 Topics: Adult; Anticoagulants; Blood Coagulation Disorders; Child; Dabigatran; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans; Pain; Retrospective Studies; Vascular Malformations	2023
Pharmacogenomics of anticoagulation therapy: the last 10 years. Pharmacogenomics, 2019, Volume: 20, Issue:16 Topics: Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; Dabigatran; Humans; Pharmacogenetics; Warfarin	2019
Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants: Limitations and Solutions. Stroke, 2017, Volume: 48, Issue:9 Topics: Aged; Aged, 80 and over; Antithrombins; Blood Coagulation Disorders; Blood Coagulation Tests; Dabigatran; Emergencies; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Partial Thromboplastin Time; Point-of-Care Testing; Prothrombin Time; Pyrazoles; Pyridones; Rivaroxaban; Sensitivity and Specificity; Stroke; Thrombin Time; Thrombolytic Therapy	2017
Precision Correction of Coagulopathy or Prothrombin Complex Concentrates?: Reversal Options for Dabigatran following Trauma. Anesthesiology, 2017, Volume: 127, Issue:5 Topics: Anticoagulants; Blood Coagulation Disorders; Blood Coagulation Factors; Dabigatran; Humans	2017
QCM-D surpassing clinical standard for the dose administration of new oral anticoagulant in the patient of coagulation disorders. Biosensors & bioelectronics, 2018, May-01, Volume: 104 Topics: Biosensing Techniques; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Dabigatran; Factor V; Factor Xa; Female; Humans; Male; Partial Thromboplastin Time; Quartz Crystal Microbalance Techniques; Thrombin	2018
Dabigatran etexilate in the treatment of localized intravascular coagulopathy associated with venous malformations. Thrombosis research, 2018, Volume: 168 Topics: Adult; Anticoagulants; Blood Coagulation Disorders; Blood Coagulation Tests; Dabigatran; Female; Humans; Vascular Malformations; Young Adult	2018
Volume replacement strategies do not impair the binding of dabigatran to idarucizumab: Porcine model of hemodilution. PloS one, 2019, Volume: 14, Issue:1 Topics: Animals; Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Blood Coagulation Disorders; Blood Volume; Dabigatran; Hemodilution; Male; Models, Animal; Plasma Substitutes; Sus scrofa	2019
[Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery]. Annales francaises d'anesthesie et de reanimation, 2014, Volume: 33, Issue:1 Topics: Acute Kidney Injury; Aged, 80 and over; Alzheimer Disease; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation Disorders; Dabigatran; Diabetes Mellitus, Type 2; Drug Overdose; Hemorrhage; Humans; Hyperkalemia; Male; Neoplasms; Phlebitis; Renal Dialysis	2014
The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders. Journal of thrombosis and haemostasis : JTH, 2015, Volume: 13, Issue:11 Topics: Activated Protein C Resistance; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antibody Specificity; Antithrombins; Blood Coagulation Disorders; Blood Coagulation Tests; Dabigatran; Dose-Response Relationship, Immunologic; False Negative Reactions; False Positive Reactions; Hemophilia A; Humans; Lupus Coagulation Inhibitor	2015
Thromboelastogram does not detect pre-injury anticoagulation in acute trauma patients. The American journal of emergency medicine, 2017, Volume: 35, Issue:4 Topics: Aged; Aged, 80 and over; Anticoagulants; Blood Coagulation Disorders; Case-Control Studies; Cohort Studies; Dabigatran; Factor Xa Inhibitors; Female; Humans; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Retrospective Studies; Thrombelastography; Warfarin; Wounds, Nonpenetrating	2017
The future of anticoagulant therapy. Cardiovascular therapeutics, 2012, Volume: 30, Issue:5 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Disorders; Dabigatran; Drug Approval; Fibrinolytic Agents; Humans; Morpholines; Rivaroxaban; Stroke; Thiophenes	2012
New directions in anticoagulation. The American journal of medicine, 2012, Volume: 125, Issue:3 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Disorders; Clinical Trials as Topic; Dabigatran; Humans; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin	2012
Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate. Journal of thrombosis and haemostasis : JTH, 2012, Volume: 10, Issue:9 Topics: Animals; Anticoagulants; Antithrombin Proteins; Benzimidazoles; Blood Coagulation Disorders; Dabigatran; Mice; Prothrombin; Pyridines; Warfarin	2012
The use of FEIBA® in the correction of coagulation abnormalities induced by dabigatran. International journal of laboratory hematology, 2013, Volume: 35, Issue:2 Topics: Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Clinical Chemistry Tests; Dabigatran; Humans; Research Design	2013
When dabigatran and trauma collide. The American surgeon, 2013, Volume: 79, Issue:1 Topics: Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Disorders; Dabigatran; Fatal Outcome; Female; Hemorrhage; Humans; Male; Middle Aged; Wounds and Injuries	2013